Related Experiment Video
Updated: May 13, 2026

11:10
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
Polyclonal antibody to soman-tyrosine.
Bin Li1, Ellen G Duysen, Marie-Thérèse Froment
1Eppley Institute, University of Nebraska Medical Center , Omaha, Nebraska 68198-5950, United States.
Chemical Research in Toxicology
|March 9, 2013
Summary
Researchers developed a high-affinity antibody that specifically detects soman (a nerve agent) bound to tyrosine residues in proteins. This antibody could help identify unexpected targets of soman toxicity.
Area of Science:
- Biochemistry
- Immunology
- Toxicology
Background:
- Soman, a potent nerve agent, covalently binds to tyrosine residues in various proteins.
- Understanding soman's protein interactions is crucial for assessing its toxicity and developing countermeasures.
Purpose of the Study:
- To generate a high-affinity antibody capable of specifically recognizing soman-modified tyrosine residues.
- To investigate the potential of this antibody in identifying secondary targets of soman toxicity.
Main Methods:
- Covalent modification of a pentapeptide with soman, followed by conjugation to keyhole limpet hemocyanin.
- Immunization of rabbits with the conjugate to produce polyclonal antiserum.
- Characterization of the antibody's specificity using ELISA and Western blot assays on soman-labeled proteins.
Main Results:
- The produced polyclonal antiserum specifically recognized soman-labeled human albumin and transferrin, independent of surrounding amino acid sequences.
- The antibody demonstrated high affinity, with an IC50 of 10(-11) M in competition ELISA.
- A detection limit of 0.01 μg (15 picomoles) of soman-labeled albumin was achieved on Western blots.
Conclusions:
- A high-affinity polyclonal antibody specifically recognizing soman-tyrosine adducts across different proteins has been successfully produced.
- This antibody holds potential for identifying novel, secondary targets of soman toxicity.
- The findings contribute to a better understanding of soman's mechanism of action and potential diagnostic applications.
More Related Videos
Related Concept Videos
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...

